MicroRNA-29 targets FGF2 and inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells via PI3K/AKT signaling pathway
M. Xu, G.-L. Tian, C.-C. Hao, M. Shi, D.-J. Zha, K. Liang Department of Radiation Oncology, Air Force Medical University, Xi’an, Shaanxi, China.
The article “MicroRNA-29 targets FGF2 and inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells via PI3K/AKT signaling pathway, by M. Xu, G.-L. Tian, C.-C. Hao, M. Shi, D.-J. Zha, K. Liang, published in Eur Rev Med Pharmacol Sci 2019; 23 (12): 5215-5222. DOI: 10.26355/eurrev_201906_18186. PMID: 31298371” has been withdrawn from the authors.
The Publisher apologizes for any inconvenience this may cause.
https://www.staging.europeanreview.org/article/18186
Free PDF Download
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
M. Xu, G.-L. Tian, C.-C. Hao, M. Shi, D.-J. Zha, K. Liang
MicroRNA-29 targets FGF2 and inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells via PI3K/AKT signaling pathway
Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 13
Pages: 7199-7199
DOI: 10.26355/eurrev_202007_21849